Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.

Current opinion in organ transplantation - 1 Dec 2008

Danger Richard, Giral Magali, Soulillou Jean-Paul, Brouard Sophie

Abstract excerpt

PURPOSE OF REVIEW: To summarize predictive low-risk parameters of renal allograft recipients for purposes of improving the initiation of calcineurin inhibitor withdrawal protocols. RECENT FINDINGS: Clinical trials have demonstrated the potential global benefit of calcineurin inhibitor interruption protocols on graft survival despite being associated with an increased rate of acute rejection episodes, thus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcineurin Inhibitors
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Graft Survival

Share to Immunosuppressive Agents

Share to Kidney Diseases

Share to Kidney Transplantation

Share to Transplantation, Homologous

Source

Identifiers

PMID: 19060551
DOI: 10.1097/MOT.0b013e3283193bd8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.PMID 19060551Read ↗

Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach.Semantic proximity Read ↗

Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation.Semantic proximity Read ↗

Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.Semantic proximity Read ↗

Time-Limited Therapy With Belatacept in Kidney Transplant RecipientsSemantic proximity Read ↗

Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes.Semantic proximity Read ↗

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapySemantic proximity Read ↗

CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study.Semantic proximity Read ↗

Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.Semantic proximity Read ↗

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial.Semantic proximity Read ↗

Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids.Semantic proximity Read ↗

Non-immunological complications following kidney transplantationSemantic proximity Read ↗

Phenotype of immunosuppression reduction after kidney transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.